ORIGINAL ARTICLE
LARGE-SCALE SCREENING FOR SARS-COV-2 INFECTION IN ENT PATIENTS DURING THE COVID-19 PANDEMIC
,
 
 
 
 
More details
Hide details
1
Department of Otolaryngology and Laryngological Oncology, Audiology and Phoniatrics, Medical University, Poland
 
 
A - Research concept and design; B - Collection and/or assembly of data; C - Data analysis and interpretation; D - Writing the article; E - Critical revision of the article; F - Final approval of article;
 
 
Submission date: 2022-10-19
 
 
Final revision date: 2022-11-18
 
 
Acceptance date: 2022-11-22
 
 
Online publication date: 2022-12-29
 
 
Publication date: 2022-12-29
 
 
Corresponding author
Katarzyna Szkutnik   

Department of Otolaryngology and Laryngological Oncology, Audiology and Phoniatrics, Medical University, Żeromskiego 113, 90-549, Łódź, Poland
 
 
J Hear Sci 2022;12(4):26-31
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Based of the authors’ own material, the results of screening tests for SARS-CoV-2 infection were analysed in ENT patients scheduled for a diagnostic procedure or elective surgery in our hospital during 10 months of the COVID-19 pandemic.

Material and methods:
The study was carried out on 546 women, aged 18–94 years and 696 men, aged 18–87 years, who were scheduled for hospitalisation between 1 May 2020 and 28 February 2021. PCR and antigen tests for the SARS-CoV-2 virus were performed in all patients. A negative result was a prerequisite for admission in order to undergo a diagnostic procedure or surgery.

Results:
SARS-CoV-2 virus testing was performed in 1242 patients, 44% of whom were female and 56% male. In terms of age distribution, the peak for women was either 51–60 years (7.3%) or 61–70 years (10.5%), while for males the peak age was lower, at 18–30 years (10.5%) or 31–40 years (12.1%). In each month, a similar number of tests were performed, which was related to our contract with the Polish National Health Fund. To allow for a patient scheduled for a procedure being COVID-19 positive and unable to attend, the department asked us to qualify more patients for surgery in each week so as to keep up the standard number of surgical treatments. Our data showed that 1.5% of women and 2.5% of men became COVID-19 positive. The number of infected patients increased gradually from October 2020 to January 2021, related to an increase in morbidity.

Conclusions:
Of the 1242 patients, 236 (19.0%) women and 231 (18.6%) men were scheduled for a diagnostic procedure, while 310 (25.0%) women and 465 (37.4%) men were tested for elective surgery. Screening tests for SARS-CoV-2 infection in all these patients allowed us to disqualify patients from hospitalization if they had a positive result, thereby limiting the transmission of the virus while allowing us to fulfill our contract.

 
REFERENCES (17)
1.
Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, et al. New coronavirus associated with human respiratory disease in China. Nature, 2020; 579: 265–9.
 
2.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for viral origin and receptor binding. Lancet, 2020; 395(10224): 565–74.
 
3.
Tan W, Zhao X, Ma X, Wang W, Niu P, Xu W, et al. New coronavirus genome identified in pneumonia cases group: Wuhan, China 2019–2020. Chinese weekly CDC; 2020; 2: 61–2.
 
4.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of 2019 novel coronavirus patients in Wuhan, China. Lancet, 2020; 395(10223): 497–506.
 
5.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. Pneumonia outbreak associated with a novel coronavirus possibly of bat origin. Nature, 2020; 579(7798): 270–3.
 
6.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. The dynamics of early transmission in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020; 382(13): 1199–207.
 
7.
Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents, 2020, 55(3): 105.
 
8.
Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu MG, Zhang LJ. Coronavirus disease 2019 (COVID-19): perspective from China. Radiology, 2020; 296(2): E15-25.
 
9.
Coronaviridae Study Group at the International Committee on Virus Taxonomy. Species. Coronavirus associated with severe acute respiratory syndrome: 2019-nCoV classification and naming it SARS-CoV-2. Nat Microbiol, 2020; 5(4): 536–44.
 
10.
Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: a short frontline perspective. J Infect, 2020; 80(4): 373–7.
 
11.
Guan W, Ni Z, Hu Y, Liang W-H, Ou C-Q, He J-H, et al. Clinical characteristics of 2019 coronavirus disease in China. N Engl J Med, 2020; 382(18): 1708–20.
 
12.
Martínez AG, Gálvez MA, Sanz SR, Ruiz PH, Morillas AG, Sánchez TE. Incidence of smell and taste disorders and associated factors in patients with mild to moderate COVID-19. Otolaryngol Pol, 2021; 75 (5): 31–8.
 
13.
Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M, Talbot PJ. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses, 2019; 12(1): 14–9.
 
14.
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild to moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngology, 2020; 227(8): 2251–61.
 
15.
Suzuki M, Saito K, Min WP, Vladau C, Toida K, Itoh H, Murakami S. Identification of viruses in patients with post viral olfactory dysfunction. Laryngoscope, 2007; 117(2): 272–7.
 
16.
Carrillo-Larco RM, Altez-Fernandez C. Anosmia and dysgeusia in COVID-19: a systematic review. Wellcome Open Res, 2020; 5: 94–9.
 
17.
Coronavirus in Poland: current and historical data. Report of 28 September 2022. Available from: https://koronawirusunas.pl [Accessed: 23.11.2022].
 
Journals System - logo
Scroll to top